These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Clinical efficacy of stereotactic ablative radiotherapy for lung metastases arising from colorectal cancer. Jung J; Song SY; Kim JH; Yu CS; Kim JC; Kim TW; Jeong SY; Kim SS; Choi EK Radiat Oncol; 2015 Nov; 10():238. PubMed ID: 26588896 [TBL] [Abstract][Full Text] [Related]
5. A matched-pair analysis of stereotactic body radiotherapy (SBRT) for oligometastatic lung tumors from colorectal cancer versus early stage non-small cell lung cancer. Wang X; Zamdborg L; Ye H; Grills IS; Yan D BMC Cancer; 2018 Oct; 18(1):962. PubMed ID: 30305131 [TBL] [Abstract][Full Text] [Related]
6. KRAS discordance between primary and metastatic tumor in patients with metastatic colorectal carcinoma. Siyar Ekinci A; Demirci U; Cakmak Oksuzoglu B; Ozturk A; Esbah O; Ozatli T; Celik B; Budakoglu B; Turker I; Bal O; Turan N J BUON; 2015; 20(1):128-35. PubMed ID: 25778307 [TBL] [Abstract][Full Text] [Related]
7. Predictive factors for local control in primary and metastatic lung tumours after four to five fraction stereotactic ablative body radiotherapy: a single institution's comprehensive experience. Thibault I; Poon I; Yeung L; Erler D; Kim A; Keller B; Lochray F; Jain S; Soliman H; Cheung P Clin Oncol (R Coll Radiol); 2014 Nov; 26(11):713-9. PubMed ID: 25085765 [TBL] [Abstract][Full Text] [Related]
8. Safety and Efficacy of Stereotactic Ablative Radiation Therapy for Renal Cell Carcinoma Extracranial Metastases. Wang CJ; Christie A; Lin MH; Jung M; Weix D; Huelsmann L; Kuhn K; Meyer J; Desai N; Kim DWN; Pedrosa I; Margulis V; Cadeddu J; Sagalowsky A; Gahan J; Laine A; Xie XJ; Choy H; Brugarolas J; Timmerman R; Hannan R Int J Radiat Oncol Biol Phys; 2017 May; 98(1):91-100. PubMed ID: 28587057 [TBL] [Abstract][Full Text] [Related]
9. Impact of Single-organ Metastasis to the Liver or Lung and Genetic Mutation Status on Prognosis in Stage IV Colorectal Cancer. Cavallaro P; Bordeianou L; Stafford C; Clark J; Berger D; Cusack J; Kunitake H; Francone T; Ricciardi R Clin Colorectal Cancer; 2020 Mar; 19(1):e8-e17. PubMed ID: 31899147 [TBL] [Abstract][Full Text] [Related]
10. Outcomes of single fraction stereotactic ablative radiotherapy for lung metastases. Filippi AR; Badellino S; Guarneri A; Levis M; Botticella A; Mantovani C; Ragona R; Racca P; Buffoni L; Novello S; Ricardi U Technol Cancer Res Treat; 2014 Feb; 13(1):37-45. PubMed ID: 23819496 [TBL] [Abstract][Full Text] [Related]
11. Disease course of lung oligometastatic colorectal cancer treated with stereotactic body radiotherapy. Nicosia L; Cuccia F; Mazzola R; Ricchetti F; Figlia V; Giaj-Levra N; Rigo M; Tomasini D; Pasinetti N; Corradini S; Ruggieri R; Alongi F Strahlenther Onkol; 2020 Sep; 196(9):813-820. PubMed ID: 32399637 [TBL] [Abstract][Full Text] [Related]
12. Stereotactic ablative radiation therapy as first local therapy for lung oligometastases from colorectal cancer: a single-institution cohort study. Filippi AR; Badellino S; Ceccarelli M; Guarneri A; Franco P; Monagheddu C; Spadi R; Ragona R; Racca P; Ricardi U Int J Radiat Oncol Biol Phys; 2015 Mar; 91(3):524-9. PubMed ID: 25542308 [TBL] [Abstract][Full Text] [Related]
13. Curative-intent radiotherapy in patients with oligometastatic lesions from colorectal cancer: A single-center study. He X; Zhang P; Li Z; Bi F; Xu F; Wang X; Shen Y; Li Q; Qiu M Medicine (Baltimore); 2018 Oct; 97(40):e12601. PubMed ID: 30290630 [TBL] [Abstract][Full Text] [Related]
14. Stereotactic Ablative Radiotherapy (SABR) in inoperable oligometastatic disease from colorectal cancer: a safe and effective approach. Comito T; Cozzi L; Clerici E; Campisi MC; Liardo RL; Navarria P; Ascolese A; Tozzi A; Iftode C; De Rose F; Villa E; Personeni N; Rimassa L; Santoro A; Fogliata A; Mancosu P; Tomatis S; Scorsetti M BMC Cancer; 2014 Aug; 14():619. PubMed ID: 25163798 [TBL] [Abstract][Full Text] [Related]
15. Analyses of local control and survival after stereotactic body radiotherapy for pulmonary oligometastases from colorectal adenocarcinoma. Yamamoto T; Niibe Y; Matsumoto Y; Onishi H; Aoki M; Nishikawa A; Oh RJ; Shintani T; Yahara K; Ozaki M; Manabe Y; Jingu K J Radiat Res; 2020 Nov; 61(6):935-944. PubMed ID: 32940330 [TBL] [Abstract][Full Text] [Related]
16. 30 Gy single dose stereotactic body radiation therapy (SBRT): Report on outcome in a large series of patients with lung oligometastatic disease. Osti MF; Agolli L; Valeriani M; Reverberi C; Bracci S; Marinelli L; De Sanctis V; Cortesi E; Martelli M; De Dominicis C; Minniti G; Nicosia L Lung Cancer; 2018 Aug; 122():165-170. PubMed ID: 30032826 [TBL] [Abstract][Full Text] [Related]
17. Late metastatic presentation is associated with improved survival and delayed wide-spread progression after ablative stereotactic body radiotherapy for oligometastasis. Chen X; Chen H; Poon I; Erler D; Badellino S; Biswas T; Dagan R; Foote M; Louie AV; Ricardi U; Sahgal A; Redmond KJ Cancer Med; 2021 Sep; 10(18):6189-6198. PubMed ID: 34432390 [TBL] [Abstract][Full Text] [Related]
18. A multicenter LArge retrospectIve daTabase on the personalization of stereotactic ABlative radiotherapy use in lung metastases from colon-rectal cancer: The LaIT-SABR study. Nicosia L; Franceschini D; Perrone-Congedi F; Casamassima F; Gerardi MA; Rigo M; Mazzola R; Perna M; Scotti V; Fodor A; Iurato A; Pasqualetti F; Gadducci G; Chiesa S; Niespolo RM; Bruni A; Alicino G; Frassinelli L; Borghetti P; Di Marzo A; Ravasio A; De Bari B; Sepulcri M; Aiello D; Mortellaro G; Sangalli C; Franceschini M; Montesi G; Aquilanti FM; Lunardi G; Valdagni R; Fazio I; Scarzello G; Corti L; Vavassori V; Maranzano E; Magrini SM; Arcangeli S; Gambacorta MA; Valentini V; Paiar F; Ramella S; Di Muzio NG; Livi L; Jereczek-Fossa BA; Osti MF; Scorsetti M; Alongi F Radiother Oncol; 2022 Jan; 166():92-99. PubMed ID: 34748855 [TBL] [Abstract][Full Text] [Related]
19. Local Recurrence Outcomes of Colorectal Cancer Oligometastases Treated With Stereotactic Ablative Radiotherapy. Benson KRK; Sandhu N; Zhang C; Ko R; Toesca DAS; Lee PE; Von Eyben R; Diehn M; Gensheimer M; Maxim PG; Bush K; Loo BW; Soltys SG; Pollom EL; Chang DT Am J Clin Oncol; 2021 Nov; 44(11):559-564. PubMed ID: 34534143 [TBL] [Abstract][Full Text] [Related]
20. Stereotactic Body Radiotherapy for Lung Metastases from Colorectal Cancer: Prognostic Factors for Disease Control and Survival. Qiu H; Katz AW; Chowdhry AK; Usuki KY; Singh DP; Metcalfe S; Cheruvu P; Chen Y; Okunieff P; Milano MT Am J Clin Oncol; 2018 Jan; 41(1):53-58. PubMed ID: 26270442 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]